Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Effects of endogenous testosterone and estradiol on sexual behavior in normal young men.

Bagatell CJ, Heiman JR, Rivier JE, Bremner WJ.

J Clin Endocrinol Metab. 1994 Mar;78(3):711-6. Erratum in: J Clin Endocrinol Metab 1994 Jun;78(6):1520.

PMID:
8126146
2.

Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.

Tom L, Bhasin S, Salameh W, Steiner B, Peterson M, Sokol RZ, Rivier J, Vale W, Swerdloff RS.

J Clin Endocrinol Metab. 1992 Aug;75(2):476-83.

PMID:
1639948
3.

Physiological levels of estradiol stimulate plasma high density lipoprotein2 cholesterol levels in normal men.

Bagatell CJ, Knopp RH, Rivier JE, Bremner WJ.

J Clin Endocrinol Metab. 1994 Apr;78(4):855-61.

PMID:
8157711
4.

Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels.

Bagatell CJ, Knopp RH, Vale WW, Rivier JE, Bremner WJ.

Ann Intern Med. 1992 Jun 15;116(12 Pt 1):967-73.

PMID:
1586105
5.

Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.

Bagatell CJ, Matsumoto AM, Christensen RB, Rivier JE, Bremner WJ.

J Clin Endocrinol Metab. 1993 Aug;77(2):427-32.

PMID:
8345047
6.

The effects of exogenous testosterone on sexuality and mood of normal men.

Anderson RA, Bancroft J, Wu FC.

J Clin Endocrinol Metab. 1992 Dec;75(6):1503-7.

PMID:
1464655
7.

A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men.

Bagatell CJ, McLachlan RI, de Kretser DM, Burger HG, Vale WW, Rivier JE, Bremner WJ.

J Clin Endocrinol Metab. 1989 Jul;69(1):43-8.

PMID:
2499592
8.
9.

Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men.

Bagatell CJ, Heiman JR, Matsumoto AM, Rivier JE, Bremner WJ.

J Clin Endocrinol Metab. 1994 Aug;79(2):561-7.

PMID:
8045977
10.

Hormonal responses to a potent gonadotropin hormone-releasing hormone antagonist in normal elderly men.

Tenover JS, Dahl KD, Vale WW, Rivier JE, Bremner WJ.

J Clin Endocrinol Metab. 1990 Oct;71(4):881-8.

PMID:
2205625
11.

Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.

Pavlou SN, Brewer K, Farley MG, Lindner J, Bastias MC, Rogers BJ, Swift LL, Rivier JE, Vale WW, Conn PM, et al.

J Clin Endocrinol Metab. 1991 Dec;73(6):1360-9.

PMID:
1955518
12.

Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH.

Dubourdieu S, Charbonnel B, D'Acremont MF, Carreau S, Spitz IM, Bouchard P.

J Clin Endocrinol Metab. 1994 Feb;78(2):343-7.

PMID:
8106622
13.

Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.

Pavlou SN, Wakefield G, Schlechter NL, Lindner J, Souza KH, Kamilaris TC, Konidaris S, Rivier JE, Vale WW, Toglia M.

J Clin Endocrinol Metab. 1989 Feb;68(2):446-54.

PMID:
2537334
14.

Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone.

Swerdloff RS, Bagatell CJ, Wang C, Anawalt BD, Berman N, Steiner B, Bremner WJ.

J Clin Endocrinol Metab. 1998 Oct;83(10):3527-33.

PMID:
9768659
15.

Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.

Pavlou SN, Veldhuis JD, Lindner J, Souza KH, Urban RJ, Rivier JE, Vale WW, Stallard DJ.

J Clin Endocrinol Metab. 1990 May;70(5):1472-8.

PMID:
2110578
17.

Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback.

Hayes FJ, Seminara SB, Decruz S, Boepple PA, Crowley WF Jr.

J Clin Endocrinol Metab. 2000 Sep;85(9):3027-35.

PMID:
10999781
18.
19.

Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men.

Finkelstein JS, Whitcomb RW, O'Dea LS, Longcope C, Schoenfeld DA, Crowley WF Jr.

J Clin Endocrinol Metab. 1991 Sep;73(3):609-20.

PMID:
1908484
20.

The role of aromatization in testosterone supplementation: effects on cognition in older men.

Cherrier MM, Matsumoto AM, Amory JK, Ahmed S, Bremner W, Peskind ER, Raskind MA, Johnson M, Craft S.

Neurology. 2005 Jan 25;64(2):290-6.

PMID:
15668427

Supplemental Content

Support Center